Modulight is developing a transformative optogenetic platform that precisely silences pathological neural activity while preserving normal brain function. Using gene therapy and a novel light-activated inhibitory opsin, the technology enables targeted, reversible modulation of neural circuits, offering a highly precise approach for treating neurological disorders.